Jay Feingold, MD, PhD, is Senior Vice President, Chief Medical Officer, and Head of Oncology Clinical Development at ADC Therapeutics.
Dr. Feingold has extensive experience in academic medicine and the pharmaceutical industry. Before joining ADC Therapeutics, he was Vice President of US Medical Affairs and Chairman of the Global Medical Affairs Oversight Committee at Daiichi Sankyo. Dr. Feingold was previously Vice President of Global Oncology Clinical Development and Global Therapy Area Director of Oncology at Wyeth. Before joining Wyeth, Dr. Feingold was a member of the Departments of Medicine and Pediatrics and Associate Director of the Bone Marrow Transplant Program at the University of Connecticut, overseeing the Alternative Donor and Pediatric Transplant Programs.
Dr. Feingold received his MD and PhD from the Albert Einstein College of Medicine and trained in Pediatrics and Pediatric Hematology and Oncology at the UCLA Center for the Health Sciences.